Clinical Trial Update: Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients [NA]

View source ↗

Summary

The clinical trial NCT00709293 investigating intraoperative thymoglobulin to decrease ischemia-reperfusion injury in pediatric heart transplant recipients has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Heart Failure
• Ischemia-reperfusion Injury

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Ischemia Reperfusion Injury, Heart Transplantation | NA | Status: WITHDRAWN